HT analyses the impact of the sweeping tariffs announced by President Trump on Wednesday on the economy and various sectors.

According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

First, imposing a 26% tariff on medical devices imported from India will be a sharp escalation from previous tariffs.

The Trump-led US administration announced new tariffs on April 2, 2025, imposing a 26 percent tariff on India, impacting its ...

Despite the 26% tariff imposed by the US, India showed resilience with only a 0.40% decline in markets, while regional peers ...

Of the $91 billion worth of India’s exports to the US, nearly $20 billion are expected to come under some form of exemption ...

India’s primary exports to the US include pharmaceuticals, telecom equipment, gemstones, petroleum products, gold jewellery, ...

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...

Pharmaceutical companies breathed a sigh of relief on Wednesday, but the tariff reprieve could prove fleeting.

The fourth edition of the West Africa Pharma Healthcare Exhibition is set to take place from May 6-8, at the Accra International ...

Learn more about the biotech and biopharma industry in Europe, including market trends, investments, fundraisings, M&A, and ...

Pharma stocks rise as Trump exempts pharmaceuticals from reciprocal tariffs. Indian, UK, and Japanese drugmakers gain.